HXTL (01085) released its interim results, showing a net loss attributable to shareholders of 70.42 million yuan, a year-on-year change from profit to loss.
Hengxin Technology (01085) released its interim results for the six months ended June 30, 2025, achieving revenue...
HXTL (01085) released the interim results for the six months ending June 30, 2025. The group achieved a revenue of 1.022 billion RMB, a decrease of 8.35% compared to the same period last year. The net loss attributable to equity shareholders of the company was 70.42 million RMB, compared to a profit of 26.589 million RMB in the same period last year. The basic loss per share was 0.152 RMB.
The announcement stated that the revenue in the first half of 2025 decreased compared to the first half of 2024, mainly due to a decrease in revenue from the wireless communication business segment. In the first half of 2025, the revenue from the wireless communication business segment was approximately 854 million RMB, a decrease of approximately 115 million RMB or 11.9% compared to approximately 969 million RMB in the first half of 2024.
Related Articles

Angang Steel (00347): Tian Yong appointed as the company's general manager.

Lingbao Gold (03330): Zhao Li has been appointed as a member of the Nominating Committee.

HIGH FASHION (00608) announces its interim results, with a net profit attributable to shareholders of HKD 41.747 million, a decrease of 21.68% year-on-year.
Angang Steel (00347): Tian Yong appointed as the company's general manager.

Lingbao Gold (03330): Zhao Li has been appointed as a member of the Nominating Committee.

HIGH FASHION (00608) announces its interim results, with a net profit attributable to shareholders of HKD 41.747 million, a decrease of 21.68% year-on-year.

RECOMMEND

Analysts Respond to Trump’s Dismissal of Fed Governor Cook as a Further Assault on Central Bank Independence
26/08/2025

U.S. Proposes Including Copper, Silicon, Silver on 2025 Critical Minerals List Amid Supply Chain Concerns
26/08/2025

Trump Vows to Slash U.S. Drug Prices by Up to 1500%, Triggering Sell-Off in Pharma Stocks
26/08/2025